Literature DB >> 31912935

Cytokine characteristic of cerebrospinal fluid from children with enteroviral meningitis compared to bacterial meningitis.

Jialu Xu1, Jingjing Jiang1, Yi Zhang1, Wei Li2.   

Abstract

BACKGROUND: Enteroviruses are the most common etiological agent for viral encephalitis, but it is uncertain whether the cytokines have the ability to differentiate enteroviral meningitis (EVM) from bacterial meningitis (BM).
METHODS: A retrospective study was performed at the Children's Hospital, Zhejiang University School of Medicine from August 2016 and August 2019. CSF and/or blood specimens were collected for microbiological culture, viruses, and cytokine detection.
RESULTS: Forty-three patients were confirmed with meningitis, 27 patients with EVM, and 16 with BM. Children with EVM were older compared with BM and Control group (P < .001). The most common presenting symptom in children with EVM was fever (96.3%) followed by headache (88.9%) and vomiting (66.7%). The occurrence of seizure was lower in both EVM and BM groups (P < .001). Serum IL-6 and serum IL-10 were lower in EVM group than BM (P = .02) and control group (IL-6, P = .01; IL-10, P < .001). IL-6, IL-10, and IFN-γ levels showed obviously increase in CSF (P < .001, respectively) in EVM group, while only IL-6 increased in CSF (P < .001) in BM group. CSF concentrations of cytokines IL-6, IL-10, TNF, and IFN-γ in children with EVM and BM were both higher than Control group (P < .001). But compared EVM group to BM group, CSF IL-2 (P = .13), IL-6 (P = .37), IL-10 (P = .98), TNF (P = .54), and IFN-γ (P = .53) showed no difference between two groups.
CONCLUSIONS: CSF cytokines elevated in both virus and bacterial meningitis, while serum elevation only occurred in bacterial infection. Still, we could not distinguish enteroviral meningitis from bacterial meningitis with the parameters of CSF cytokines IL-2, IL-6, IL-10, TNF, and IFN-γ.
© 2020 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  bacterial meningitis; cytokines; enteroviral meningitis

Mesh:

Substances:

Year:  2020        PMID: 31912935      PMCID: PMC7246373          DOI: 10.1002/jcla.23198

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


INTRODUCTION

Enteroviruses (EVs) are the most common etiological agent for viral meningitis in China.1 EVs are small, single‐stranded, positive sense RNA viruses including 11 species of human EV (Enterovirus A‐L and Rhinovirus A‐C).2 Enteroviral meningitis (EVM) are predominantly reported among children and always present as a milder clinical illness than other infectious causes 3 which only need supportive therapy. On the other hand, bacterial meningitis (BM) is still associated with a high morbidity and mortality rate.4 Appropriate antibiotics treatment is essential to optimize outcomes. In the previous study, cytokines were regarded as important roles in meningeal inflammation in patients with CNS infection. Cerebrospinal fluid (CSF) cytokines were reported as useful markers to distinguish viral and bacterial meningitis.5, 6 In this study, we investigated the cytokine profiles in the CSF and serum of children with EVM and BM, as well as with febrile seizures as a control group, to verify whether cytokines could be a useful indicator to distinguish EVM and BM.

PATIENTS AND METHODS

Study population

The study was designed as a retrospective study using the database of children older than 1 month of age at the Children's Hospital, Zhejiang University School of Medicine between August 2016 and August 2019. The study was approved with the ethics committee of Children's Hospital, Zhejiang University School of Medicine (2019‐IRB‐091). We categorized patients into three groups: (a) EVM group: Patients with EVM were confirmed by the presence of pleocytosis and detection of enteroviral nucleic acid detection in CSF using polymerase chain reaction (PCR).7 Patients who received immunomodulators or had other viral such as Epstein‐Barr virus (EBV), herpes simplex virus (HSV), or bacterial infections, or immune disorders were excluded; (b) BM group: Patients with bacterial meningitis were diagnosed as having CSF white blood cell counts >50 × 106 cells/L with predominant neutrophils, CSF blood glucose ratio <0.5, CSF protein >50 mg/dL and positive Gram stain, and/or CSF culture; and (c) Control group: children with febrile seizures who underwent lumbar puncture and had normal CSF.

Pathogen detection

CSF specimens and blood samples were taken for microbiological culture. Samples were injected into children's blood culture bottles (BACTEC FX400, BD) for enrichment culture. Samples were then inoculated to appropriate medium according to smear results after culture positive. MALDI‐TOF (BRUKER) was used for bacterial identification and VITEK 2 compact (Biomerieux) for bacterial drug sensitivity. CLSI M100 S28/S29 were used as drug‐sensitive points. The detection for viruses in CSF was following the manufacturer's instructions. CSF samples were collected from the children with viral meningitis. For the detection of EVs, a total of 200 µL CSF were taken for virus RNA extraction by using magnetic beads following nucleic acid automatic extraction instrument (Zhi‐jiang Company). The detection of EVs in ABI Step one plus system was performed by using commercial one‐step real‐time RT‐PCR assay kit (Zhi‐jiang company).8 The real‐time RT‐PCR was conducted under these conditions: 15 minutes at 50°C, 5 minutes at 95°C, and then followed by 40 cycles of 15 seconds at 94°C and 45 seconds at 55°C. For the detection of nucleic acid of EB and HSV, a total of 50 µL CSF were mixed with 50 µL of DNA extraction solution. The mixture was boiled for 10 minutes, after which it was centrifuged at 4°C. Finally, a volume of 5 µL of the supernatant and 45 µL of PCR mix (Da'an Gene Co., Ltd.) were utilized to perform real‐time PCR using the Applied Biosystems 7500 real‐time PCR system (Applied Biosystems) according to the following protocol: 93°C for 2 minutes, 10 cycles of 93°C for 45 seconds, and 55°C for 60 seconds, followed by 30 cycles of 93°C for 30 seconds and 55°C for 45 seconds. Samples with CT value <35.0 were identified positive.

Cytokine detection

Serum and CSF concentration of cytokines interleukin (IL)‐2, IL‐6, IL‐10, tumor necrosis factor (TNF), and interferon (IFN)‐γ were quantitatively determined by the CBA kit–BDTM CBA Human Th1/Th2 Cytokine Kit II (BD Biosciences), according to the manufacturer's instructions. The minimal and maximum limits of detection for all six cytokines were 1.0 and 5000 pg/mL, respectively.

Statistical analysis

Data were analyzed using SPSS 18.0 statistical software and presented as median. We used Pearson's chi‐squared test or Fisher's exact test for categorical data and non‐parametric test. Mann‐Whitney U test, Kruskal‐Wallis test, and Nemenyi test were used for continuous data to determine significance. A two‐tailed P value of < .05 (P < .05) was considered to be statistically significant.

RESULT

Comparison of demographic and clinical features in EVM, BM, and Control groups

Of 43 patients with meningitis, 27 patients (eight girls, 19 boys) had EVM and 16 (five girls, 11 boys,) had BM. Children with EVM, that had median age of 7.2 (0.2‐14.6) years old, were older compared with BM group (median age 1.8 years old, range from 0.1 to 12.4) and Control group (median age 0.3 years old, range from 0.4 to 5.4; P < .001). The most common presenting symptom in children with EVM was fever (96.3%) followed by headache (88.9%) and vomiting (66.7%). And the occurrence of headache and vomiting was especially higher in EVM group compared with BM group and Control group (P < .05). The occurrence of seizure was lower in both EVM and BM groups (P < .001). We did lumber puncture at the time of clinical suspicion of meningitis, and the timing of lumber puncture from onset of symptoms had no difference among these three groups (P = .72). The demographic and clinical features of EVM, BM, and Control groups are presented in Table 1.
Table 1

The demographic and clinical features in EVM, BM, and Control groups

Clinical syndrome (n)EVM (27)BM (16)Control (29) P EVM vs BMEVM vs ControlBM vs Control
Gender, female/male8/195/1112/17.63   
Age, median (range), y7.2 (0.2‐14.6)0.3 (0.1‐12.4)1.8 (0.4‐5.4)<.001<0.001<0.0010.22
Fever (%)26 (96.3)16 (100)29 (100).60   
Headache (%)24 (88.9)1 (6.3)0<.001<0.001<0.0010.37
Vomiting (%)18 (66.7)5 (31.2)2 (6.7)<.0010.04<0.0010.08
Seizure (%)2 (7.4)4 (25)29 (100)<.0010.17<0.001<0.001
Timing of lumber puncture from onset of symptoms, median (range), d2 (1‐10)2.5 (1‐8)2 (1‐8).72   
The demographic and clinical features in EVM, BM, and Control groups

Cytokine expression of EVM, BM, and Control groups

The serum cytokines data in EVM, BM, and Control groups are presented in Table 2. Serum IL‐2, TNF, and IFN‐γ showed no differences among these three groups. The median level (pg/mL) of serum IL‐6 in EVM group was 15.15 (range from 1.20 to 707.60) pg/mL, which was obviously lower than BM (median 102.90, range from 2.80 to 3948.40, P = .02) and Control (median 116.10, range from 2.90 to 3726.30, P = .01) groups. Meanwhile, the median level (pg/mL) of serum IL‐10 (median 3.70, range from 1.50 to 21.80) in EVM group also appeared lower than BM (median 9.00, range from 1.90 to 137.00, P = .02) and Control (median 15.70, range from 1.00 to 281.90, P < .001) groups.
Table 2

The serum cytokines data in EVM, BM, and Control groups

Cytokine (pg/mL)EVMBMControl P EVM vs BMEVM vs ControlBM vs Control
Serum IL‐22.10 (1.00‐3.80)2.50 (1.00‐5.10)1.70 (1.00‐12.10).11   
Serum IL‐615.15 (1.20‐707.60)102.90 (2.80‐3948.40)116.10 (2.90‐3726.30).0030.020.011.0
Serum IL‐103.70 (1.50‐21.80)9.00 (1.90‐137.00)15.70 (1.00‐281.90)<.0010.02<0.0010.67
Serum TNF2.25 (1.00‐8.70)2.50 (1.00‐9.50)3.8 (1.00‐90.70).73   
Serum IFN‐γ2.35 (1.00‐11.80)4.30 (1.00‐107.00)1.90 (1.00‐334.9).10   
The serum cytokines data in EVM, BM, and Control groups The median levels (pg/mL) of CSF cytokines IL‐2, IL‐6, IL‐10, TNF, and IFN‐γ in children with EVM were 1.95 (1.62‐7.10), 222.50 (96.65‐1872.40), 13.40 (8.7‐75.70), 2.00 (1.63‐5.00), and 20.10 (7.40‐88.10), respectively. Compared with serum levels, IL‐6, IL‐10, and IFN‐γ all showed obviously increase in CSF (P < .001, respectively). CSF cytokines of IL‐2, IL‐6, IL‐10, TNF, and IFN‐γ in children with BM were 3.15 (2.18‐7.50), 848.85 (165.83‐5000.00), 19.6 (3.93‐310.00), 2.15 (1.90‐68.60), and 4.80 (2.60‐647.90), respectively. Compared with serum levels, only IL‐6 showed obviously increase in CSF (P < .001). And in Control group, CSF cytokines of IL‐2, IL‐6, IL‐10, TNF, and IFN‐γ were 1.60 (1.20‐4.70), 4.60 (3.40‐46.80), 1.10 (1.00‐3.20), 1.00 (1.00‐2.10), and 1.00 (1.00‐3.00), respectively. Compared with serum levels, IL‐6, IL‐10, TNF, and IFN‐γ all decreased in CSF (P < .001, respectively). The data were shown in Figure 1.
Figure 1

The serum and CSF cytokines data in EVM, BM, and Control groups

The serum and CSF cytokines data in EVM, BM, and Control groups Comparing of CSF cytokines data in EVM, BM, and Control groups was presented in Table 3. All these cytokines had significant differences among three groups (P < .001). Compared EVM group with Control group, CSF IL‐6, IL‐10, TNF, and IFN‐γ were higher in EVM group (P < .001, respectively) except CSF IL‐2 (P = .07). Compared BM group with Control group, CSF IL‐2, IL‐6, IL‐10, TNF, and IFN‐γ were all higher in BM group (P < .001, respectively). But compared EVM group with BM group, CSF IL‐2 (P = .13), IL‐6 (P = .37), IL‐10 (P = .98), TNF (P = .54), and IFN‐γ (P = .53) all showed no difference between two groups.
Table 3

The CSF cytokines data in EVM, BM, and Control groups

Cytokine (pg/mL)EVMBMControl P EVM vs BMEVM vs ControlBM vs Control
CSF IL‐21.95 (1.62‐7.10)3.15 (2.18‐7.50)1.60 (1.20‐4.70)<.0010.130.07<0.001
CSF IL‐6222.50 (96.65‐1872.40)848.85 (165.83‐5000.00)4.60 (3.40‐46.80)<.0010.37<0.001<0.001
CSF IL‐1013.40 (8.7‐75.70)19.6 (3.93‐310.00)1.10 (1.00‐3.20)<.0010.98<0.001<0.001
CSF TNF2.00 (1.63‐5.00)2.15 (1.90‐68.60)1.00 (1.00‐2.10)<.0010.54<0.001<0.001
CSF IFN‐γ20.10 (7.40‐88.10)4.80 (2.60‐647.90)1.00 (1.00‐3.00)<.0010.53<0.001<0.001
The CSF cytokines data in EVM, BM, and Control groups

DISCUSSION

With the popularization of bacterial conjugate vaccines, the epidemiology of childhood meningitis has dramatically changed and viral causes are increasingly predominant.9 EVs are the most common etiological agent for viral meningitis. Compared children with EVM with children with BM, they had no gender difference. But children with EVM had the median age of 7.2 (0.2‐14.6) years old which was mainly preschool or school age children, while BM mainly occurred in children under 1 year old. EVM usually had a conjunction with encephalitis resulting in a “meningoencephalitis”.10, 11 The predominant symptom of EVM in our study was fever (96.3%), headache (88.9%), and vomiting (66.7%). The incidence of seizure was only 7.4%, as Berardi A et al reported the incidence of seizure was low both in infants <90 days of age and children older than 90 days of age.12 Meanwhile in adult, the incidence of seizure was also low to 4%.13 It seems enterovirus meningoencephalitis is associated with low seizure occurrence. Serum IL‐6 and serum IL‐10 were obviously lower in patients with EVM that seemed EVM could not trigger the involvement of the peripheral immune system. In CSF, IL‐6, IL‐10, and IFN‐γ showed rapidly increase in EVM group while cytokines sharply declined in control group without meningeal infection. The elevation of CSF pro‐inflammatory cytokine IL‐6, TNF, and IFN‐γ and anti‐inflammatory cytokine IL‐10 was approved in EVM,14, 15, 16 that meant meningeal inflammation could trigger a unified pro‐ and anti‐inflammatory response in viral infections.17, 18, 19, 20 Cytokine profiling could contribute to localize the site of immune activation in viral infections. Even cytokines seemed to have the ability to distinguish enterovirus infection from other viruses. Enterovirus meningoencephalitis group showed higher level of CSF IL‐6, TNF, and IL‐17 when compared to arbovirus, lentivirus, and herpes groups.21 While compared to patients with human parechovirus meningitis, CSF levels of the majority cytokines were still significantly higher in patients with EVM.22 In BM group, compared with serum, only IL‐6 elevated in CSF. IL‐6 played to amplify an acute inflammation as well as to contribute to the transition into the chronic phase of inflammation.23 Previous study reported IL‐6 as well as IL‐1β, IL‐8, TNF‐α, and GM‐CSF to be useful markers to distinguish bacterial and viral meningitis.5, 6, 24 But in our study, CSF levels of IL‐2, IL‐6, IL‐10, TNF, and IFN‐γ all showed no difference between EVM and BM groups. Though prominent CSF IFN‐γ elevation was found in EVM group,25 IFN‐γ was still not a sensitive indicator to distinguish EVE from BM.26 Also, we interpreted the involvement of the peripheral immune system in bacterial meningitis, while CSF and serum concentrations of the cytokines were not shown to be correlated under enterovirus infection.27

CONCLUSION

We detected the elevation of CSF pro‐inflammatory and anti‐inflammation cytokines in meningeal inflammation with both enterovirus and bacterial infection, while serum elevation only occurred in bacterial infection. Thus, we could not distinguish enteroviral meningitis from bacterial meningitis with the parameters of CSF cytokines IL‐2, IL‐6, IL‐10, TNF, and IFN‐γ. More related cytokines need to be investigated under even larger samples.
  28 in total

Review 1.  Bacteria and viruses induce production of interferon in the cerebrospinal fluid of children with acute meningitis: a study of 57 cases and review.

Authors:  T Chonmaitree; S Baron
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

2.  Serum cytokine and chemokine changes during Toscana virus meningitis.

Authors:  Jessica Rauch; Lorenzo Zammarchi; Giampaolo Corti; Alessandro Bartoloni; Alexander Schlaphof; Jonas Schmidt-Chanasit; Dennis Tappe
Journal:  Med Microbiol Immunol       Date:  2019-04-11       Impact factor: 3.402

3.  Interleukin-6 in cerebrospinal fluid as a biomarker of acute meningitis.

Authors:  Pablo García-Hernández; Belén Prieto; Eduardo Martínez-Morillo; Verónica Rodríguez; Francisco V Álvarez
Journal:  Ann Clin Biochem       Date:  2015-05-14       Impact factor: 2.057

4.  Usefulness of interleukin 6 levels in the cerebrospinal fluid for the diagnosis of bacterial meningitis.

Authors:  Waka Takahashi; Taka-aki Nakada; Ryuzo Abe; Kumiko Tanaka; Yosuke Matsumura; Shigeto Oda
Journal:  J Crit Care       Date:  2014-03-05       Impact factor: 3.425

5.  Childhood meningitis in the conjugate vaccine era: a prospective cohort study.

Authors:  Manish Sadarangani; Louise Willis; Seilesh Kadambari; Stuart Gormley; Zoe Young; Rebecca Beckley; Katherine Gantlett; Katharine Orf; Sarah Blakey; Natalie G Martin; Dominic F Kelly; Paul T Heath; Simon Nadel; Andrew J Pollard
Journal:  Arch Dis Child       Date:  2014-09-25       Impact factor: 3.791

6.  Mononuclear cells and cytokines in the cerebrospinal fluid of echovirus 30 meningitis patients.

Authors:  T Matsubara; T Matsuoka; K Katayama; T Yoshitomi; M Nishikawa; T Ichiyama; S Furukawa
Journal:  Scand J Infect Dis       Date:  2000

7.  Molecular epidemiology of enterovirus from children with herpangina or hand, foot, and mouth disease in Hangzhou, 2016.

Authors:  Wei Li; Cixiu Li; Lifang Liu; Xia Liu; Shiqiang Shang; Haiyan Mao; Yanjun Zhang
Journal:  Arch Virol       Date:  2019-07-18       Impact factor: 2.574

8.  Neutralizing antibody and interferon-alpha in cerebrospinal fluids and sera of acute aseptic meningitis.

Authors:  H Ichimura; K Shimase; I Tamura; E Kaneto; O Kurimura; Y Aramitsu; T Kurimura
Journal:  J Med Virol       Date:  1985-03       Impact factor: 2.327

9.  Cerebrospinal fluid features in adults with enteroviral nervous system infection.

Authors:  Jonas Ahlbrecht; Lilly Katrin Hillebrand; Philipp Schwenkenbecher; Tina Ganzenmueller; Albert Heim; Ulrich Wurster; Martin Stangel; Kurt-Wolfram Sühs; Thomas Skripuletz
Journal:  Int J Infect Dis       Date:  2018-02-02       Impact factor: 3.623

10.  Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study.

Authors:  Sara Bromander; Rolf Anckarsäter; Marianne Kristiansson; Kaj Blennow; Henrik Zetterberg; Henrik Anckarsäter; Caroline E Wass
Journal:  J Neuroinflammation       Date:  2012-10-24       Impact factor: 8.322

View more
  4 in total

1.  Longitudinal in vivo imaging of acute neuropathology in a monkey model of Ebola virus infection.

Authors:  William Schreiber-Stainthorp; Jeffrey Solomon; Ji Hyun Lee; Marcelo Castro; Swati Shah; Neysha Martinez-Orengo; Rebecca Reeder; Dragan Maric; Robin Gross; Jing Qin; Katie R Hagen; Reed F Johnson; Dima A Hammoud
Journal:  Nat Commun       Date:  2021-05-17       Impact factor: 14.919

2.  Cytokine characteristic of cerebrospinal fluid from children with enteroviral meningitis compared to bacterial meningitis.

Authors:  Jialu Xu; Jingjing Jiang; Yi Zhang; Wei Li
Journal:  J Clin Lab Anal       Date:  2020-01-08       Impact factor: 2.352

3.  Cytokine Expression of Lung Bacterial Infection in Newly Diagnosed Adult Hematological Malignancies.

Authors:  Zengzheng Li; Zefeng Yang; Peng Hu; Xin Guan; Lihua Zhang; Jinping Zhang; Tonghua Yang; Chaoran Zhang; Renbin Zhao
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

4.  Increased Cytokine Levels Assist in the Diagnosis of Respiratory Bacterial Infections or Concurrent Bacteremia in Patients With Non-Hodgkin's Lymphoma.

Authors:  Lihua Zhang; Jinping Zhang; Haiping He; Xiaosui Ling; Fan Li; Zefeng Yang; Jinlian Zhao; Huiyuan Li; Tonghua Yang; Shixiang Zhao; Keqian Shi; Xin Guan; Renbin Zhao; Zengzheng Li
Journal:  Front Cell Infect Microbiol       Date:  2022-04-08       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.